IkerChem specializes in the computational design and synthesis of Novel Chemical Entities (NCEs) with therapeutic applications in oncology. We focus on the development of nonpeptidic small molecular weight compounds. The lead generation process is based on a rational in silico design followed by small scale synthesis preferentially carried out by means of non-described synthetic routes. This highly enriches the industrial property value of the families of compounds generated.

In addition, we offer Contract R&D.